Updates are available Correction dated 2026-04-01
Click to view Correction: https://doi.org/10.1245/s10434-026-19544-x
-
Authors
Patel, Sefali
Petrosko, Patricia
Gallo, Phillip H.
Myers, Madeline
Gil, Louis
Nolan, Edward J.
Hosseiny, Seyed H.
Blodgett, Rose
Omstead, Ashten
Park, Hyun
Dalton, Emily
Sherry, Christopher
Goel, Ajay
Allen, Casey J.
Zaidi, Ali
Schwartz, Russell
Bartlett, David L.
Wagner, Patrick L.
LaFramboise, William A.
-
Funding
Funding for this research was provided by:
Johns Hopkins AHN Cancer Research Alliance Grant
National Human Genome Research Institute of the National Institutes of Health (R01HG010589)
Claude-Worthington Benedum Foundation Award
Pittsburgh Foundation
Highmark Health
- License Information
-
More Information
Article History
Received: 2 October 2025
Accepted: 10 February 2026
First Online: 13 March 2026
Change Date: 1 April 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-026-19544-x
Disclosure
: This work was performed as part of the AHNCI Moonshot Biomarker Program and supported in part by Highmark Health. Partial support was provided by: Johns Hopkins-AHN Cancer Research Alliance Grant (WAL), Pittsburgh Foundation (PLW), The Appendix Cancer Pseudomyxoma Peritonei Research Foundation (PLW), the Claude-Worthington Benedum Foundation Award (WAL), and National Human Genome Research Institute of the National Institutes of Health under award no. R01HG010589 (RS). These funding sources had no role in the study design, data collection, analysis, interpretation of the data, and writing of the manuscript, and do not necessarily represent the official views of the National Institutes of Health.
